06.07.2023 • News

Solenis Acquires Diversey for $4.6 Billion

Solenis, a specialty chemicals manufacturer for water-intensive industries, has completed its acquisition of Diversey, a hygiene and cleaning products provider, in an all-cash transaction valued at ~ $4.6 billion.

With this acquisition, Solenis now operates in over 130 countries with 71 manufacturing facilities and over 15,000 employees.

“We now have greatly enhanced capabilities to help our customers tackle critical sustainability challenges, reduce their environmental impact and help create a cleaner, safer world,” said John Panichella, CEO, Solenis.

Solenis has been owned by Platinum Equity since its acquisition in 2021. The majority shareholder of Diversey, Bain Capital, will now be a minority stakeholder in Solenis after the merger. 

Solenis and Diversey unite in $4.6 billion acquisition. © Solenis
Solenis and Diversey unite in $4.6 billion acquisition. © Solenis

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.